A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance

To compare enalapril 20 mg once daily with 10 mg twice daily in terms of blood pressure reduction and patient compliance. Cross-over study of patients randomly assigned to a sequence of enalapril 20 mg once daily or 10 mg twice daily in three 4-week periods following a 4-week placebo run-in. General...

Full description

Saved in:
Bibliographic Details
Published in:Journal of hypertension Vol. 17; no. 11; pp. 1627 - 1631
Main Authors: GIRVIN, B, MCDERMOTT, B. J, JOHNSTON, G. D
Format: Journal Article
Language:English
Published: Hagerstown, MD Lippincott Williams & Wilkins 01-11-1999
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract To compare enalapril 20 mg once daily with 10 mg twice daily in terms of blood pressure reduction and patient compliance. Cross-over study of patients randomly assigned to a sequence of enalapril 20 mg once daily or 10 mg twice daily in three 4-week periods following a 4-week placebo run-in. General practices in the greater Belfast and Lisburn area in Northern Ireland. Twenty-five hypertensive patients who had a mean diastolic blood pressure of between 90 and 110 mm Hg after receiving placebo for 4 weeks. Reduction in blood pressure and estimation of patient compliance. Patient compliance was superior on the once daily regimen. However, the twice daily regimen was associated with a greater blood pressure reduction which almost reached statistical significance at the 5% level. Enalapril 20 mg should be prescribed as 10 mg twice daily and measures taken to improve patient compliance.
AbstractList To compare enalapril 20 mg once daily with 10 mg twice daily in terms of blood pressure reduction and patient compliance. Cross-over study of patients randomly assigned to a sequence of enalapril 20 mg once daily or 10 mg twice daily in three 4-week periods following a 4-week placebo run-in. General practices in the greater Belfast and Lisburn area in Northern Ireland. Twenty-five hypertensive patients who had a mean diastolic blood pressure of between 90 and 110 mm Hg after receiving placebo for 4 weeks. Reduction in blood pressure and estimation of patient compliance. Patient compliance was superior on the once daily regimen. However, the twice daily regimen was associated with a greater blood pressure reduction which almost reached statistical significance at the 5% level. Enalapril 20 mg should be prescribed as 10 mg twice daily and measures taken to improve patient compliance.
OBJECTIVETo compare enalapril 20 mg once daily with 10 mg twice daily in terms of blood pressure reduction and patient compliance.DESIGNCross-over study of patients randomly assigned to a sequence of enalapril 20 mg once daily or 10 mg twice daily in three 4-week periods following a 4-week placebo run-in.SETTINGGeneral practices in the greater Belfast and Lisburn area in Northern Ireland.PATIENTSTwenty-five hypertensive patients who had a mean diastolic blood pressure of between 90 and 110 mm Hg after receiving placebo for 4 weeks.MAIN OUTCOME MEASURESReduction in blood pressure and estimation of patient compliance.RESULTSPatient compliance was superior on the once daily regimen. However, the twice daily regimen was associated with a greater blood pressure reduction which almost reached statistical significance at the 5% level.CONCLUSIONSEnalapril 20 mg should be prescribed as 10 mg twice daily and measures taken to improve patient compliance.
Author MCDERMOTT, B. J
GIRVIN, B
JOHNSTON, G. D
Author_xml – sequence: 1
  givenname: B
  surname: GIRVIN
  fullname: GIRVIN, B
  organization: Department of Therapeutics and Pharmacology, The Queen's University of Belfast, Whitla Medical Building, Belfast, United Kingdom
– sequence: 2
  givenname: B. J
  surname: MCDERMOTT
  fullname: MCDERMOTT, B. J
  organization: Department of Therapeutics and Pharmacology, The Queen's University of Belfast, Whitla Medical Building, Belfast, United Kingdom
– sequence: 3
  givenname: G. D
  surname: JOHNSTON
  fullname: JOHNSTON, G. D
  organization: Department of Therapeutics and Pharmacology, The Queen's University of Belfast, Whitla Medical Building, Belfast, United Kingdom
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1289801$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/10608477$$D View this record in MEDLINE/PubMed
BookMark eNpNkE1PxCAURYnR6Dj6FwwL464KhRZYTiZ-JSZudN1Q-maCoTBCq3Hjb5f5cJQNyeXc98g5RYc-eEAIU3JNiRI3JB8uRVlQpRQVlJIiJ1QcoAnlghVVpeQhmpCyZkXNqvIEnab0lhGpBDtGJ5TURHIhJuh7hk3oVzraFDwOCwxeO72K1uGS4H6JgzeAO23dF_6AmMaUP7HOh0-7f7AeDxD7tO63LoQOryKkNEbALnxCtH6Jtc-pHiz4YbPRWZ0nn6GjhXYJznf3FL3e3b7MH4qn5_vH-eypMIyToRBacF0qLqq6g451wLmRTBnBFQcJzPCuIlSLsuK8rVjbKc1aJWjb1mCIoGyKrrZzVzG8j5CGprfJgHPaQxhTUysmCFFlBuUWNDGkFGHRZBe9jl8NJc3affPrvtm7bzbuc_Vit2Nse-j-FbeyM3C5A3Qy2i1iNmDTH1dKJQllP7Lvjgg
CODEN JOHYD3
CitedBy_id crossref_primary_10_1046_j_1365_2125_2002_01629_x
crossref_primary_10_1002_14651858_CD000011_pub4
crossref_primary_10_1016_j_pec_2008_08_019
crossref_primary_10_1002_14651858_CD000011_pub3
crossref_primary_10_1016_j_ijnurstu_2006_07_010
crossref_primary_10_1186_1471_2377_7_20
crossref_primary_10_1097_JCN_0b013e3181d5f9c5
crossref_primary_10_1097_HJH_0b013e32832d50ef
crossref_primary_10_1371_journal_pone_0243371
crossref_primary_10_1016_j_jclinepi_2007_04_007
crossref_primary_10_1111_jch_13011
crossref_primary_10_7759_cureus_17331
crossref_primary_10_1002_14651858_CD005182_pub4
crossref_primary_10_1016_j_amepre_2022_02_019
crossref_primary_10_1007_s11906_001_0009_7
crossref_primary_10_1016_S1138_3593_09_72673_5
crossref_primary_10_2147_vhrm_1_1_9_58940
crossref_primary_10_1038_ajh_2009_207
crossref_primary_10_1097_00004872_200410000_00002
crossref_primary_10_1186_s12936_015_0645_z
crossref_primary_10_1157_13119915
crossref_primary_10_1080_08870446_2016_1273356
crossref_primary_10_1345_aph_1D268
crossref_primary_10_1007_s11606_019_05269_z
crossref_primary_10_1016_S1134_2072_01_75471_0
crossref_primary_10_1002_14651858_CD004804
crossref_primary_10_1177_009286150403800213
crossref_primary_10_4037_ccn2007_27_6_62
crossref_primary_10_1016_j_ahj_2005_01_047
crossref_primary_10_1016_S0149_2918_04_80145_0
crossref_primary_10_1093_qjmed_hci139
Cites_doi 10.1016/0140-6736(90)90944-Z
10.1038/clpt.1983.198
10.2307/2530762
10.1161/01.HYP.15.3.301
10.1001/archinte.150.9.1881
10.1038/clpt.1982.125
10.1097/00004872-199007000-00004
10.1097/00004872-199012000-00003
10.1007/BF00193697
10.1097/00004872-199412001-00014
10.1111/j.1600-0773.1990.tb00847.x
10.1038/clpt.1983.101
10.1136/hrt.60.3.177
ContentType Journal Article
Copyright 2000 INIST-CNRS
Copyright_xml – notice: 2000 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1097/00004872-199917110-00017
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1473-5598
EndPage 1631
ExternalDocumentID 10_1097_00004872_199917110_00017
10608477
1289801
Genre Comparative Study
Clinical Trial
Randomized Controlled Trial
Journal Article
GroupedDBID ---
.-D
.55
.GJ
.XZ
.Z2
01R
08R
0R~
1J1
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
AAAXR
AAGIX
AAHPQ
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASOK
AAWTL
AAXQO
AAYEP
ABASU
ABBUW
ABDIG
ABFLS
ABOCM
ABXVJ
ABZAD
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACWDW
ACWRI
ACXNZ
ADFPA
ADGIM
ADNKB
AE3
AE6
AEBDS
AENEX
AFDTB
AFFNX
AFUWQ
AGINI
AHRYX
AHVBC
AI.
AIJEX
AJIOK
AJNYG
AKULP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AWKKM
BOYCO
BQLVK
BS7
C45
CAG
COF
CS3
DIWNM
DU5
DUNZO
E.X
EBS
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FL-
FW0
GQDEL
H0~
HZ~
IKREB
IKYAY
IN~
IPNFZ
IQODW
JF9
JG8
JK3
JK8
K8S
KD2
KMI
L-C
L7B
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OCUKA
ODA
ODMTH
OHYEH
OJAPA
OL1
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
R58
RIG
RLZ
S4R
S4S
T8P
TEORI
TSPGW
V2I
VH1
VVN
W3M
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YYP
ZA5
ZFV
ZGI
ZXP
ZZMQN
AAAAV
AAIQE
AASCR
AAUEB
ABJNI
ABVCZ
ACILI
ACLDA
ACXJB
ADGGA
ADHPY
AEETU
AFEXH
AFSOK
AHOMT
AHQNM
AINUH
AJNWD
AJZMW
AMNEI
AOHHW
CGR
CUY
CVF
ECM
EEVPB
EIF
ERAAH
FCALG
GNXGY
HLJTE
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c340t-7a74a294756ded3de44c839c7494e8e3c4d501a72544b53bd9a3b971bb6ec0713
ISSN 0263-6352
IngestDate Fri Aug 16 21:57:16 EDT 2024
Thu Nov 21 21:08:02 EST 2024
Wed Oct 16 00:50:31 EDT 2024
Fri Nov 25 01:09:54 EST 2022
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Human
Hypertension
Enzyme
Single dose
Enzyme inhibitor
Cardiovascular disease
Multiple dose
Drug compliance
Peptidases
Chemotherapy
Treatment
Enalapril
Peptidyl-dipeptidase A
Hydrolases
Peptidyl-dipeptidases
Antihypertensive agent
Arterial pressure
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c340t-7a74a294756ded3de44c839c7494e8e3c4d501a72544b53bd9a3b971bb6ec0713
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-News-3
content type line 23
PMID 10608477
PQID 69370092
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_69370092
crossref_primary_10_1097_00004872_199917110_00017
pubmed_primary_10608477
pascalfrancis_primary_1289801
PublicationCentury 1900
PublicationDate 1999-11-01
PublicationDateYYYYMMDD 1999-11-01
PublicationDate_xml – month: 11
  year: 1999
  text: 1999-11-01
  day: 01
PublicationDecade 1990
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: England
PublicationTitle Journal of hypertension
PublicationTitleAlternate J Hypertens
PublicationYear 1999
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References (R12-17-20110409) 1990; 67
Ferguson (R5-17-20110409) 1982; 32
Collins (R16-17-20110409) 1991; 335
Saris (R2-17-20110409) 1983; 31
Detry (R9-17-20110409) 1995; 47
Ebbutt (R13-17-20110409) 1984; 40
Evans (R15-17-20110409) 1988; 60
Eisen (R17-17-20110409) 1990; 150
Chrysant (R6-17-20110409) 1983; 33
Meredith (R7-17-20110409) 1990; 8
Donnelly (R8-17-20110409) 1990; 15
Waeber (R10-17-20110409) 1994; 12
Simon (R3-17-20110409) 1983; 34
McMahon (R4-17-20110409) 1986; 40
OBrien (R14-17-20110409) 1990; 8
References_xml – volume: 40
  start-page: 114
  year: 1986
  ident: R4-17-20110409
  publication-title: Cur Ther Res
  contributor:
    fullname: McMahon
– volume: 31
  start-page: 334A
  year: 1983
  ident: R2-17-20110409
  publication-title: Clin Res
  contributor:
    fullname: Saris
– volume: 335
  start-page: 827
  year: 1991
  ident: R16-17-20110409
  publication-title: Lancet
  doi: 10.1016/0140-6736(90)90944-Z
  contributor:
    fullname: Collins
– volume: 34
  start-page: 459
  year: 1983
  ident: R3-17-20110409
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.1983.198
  contributor:
    fullname: Simon
– volume: 40
  start-page: 219
  year: 1984
  ident: R13-17-20110409
  publication-title: Biometrics
  doi: 10.2307/2530762
  contributor:
    fullname: Ebbutt
– volume: 15
  start-page: 301
  year: 1990
  ident: R8-17-20110409
  publication-title: Hypertension
  doi: 10.1161/01.HYP.15.3.301
  contributor:
    fullname: Donnelly
– volume: 150
  start-page: 1881
  year: 1990
  ident: R17-17-20110409
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.150.9.1881
  contributor:
    fullname: Eisen
– volume: 32
  start-page: 48
  year: 1982
  ident: R5-17-20110409
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.1982.125
  contributor:
    fullname: Ferguson
– volume: 8
  start-page: 607
  year: 1990
  ident: R14-17-20110409
  publication-title: J Hypertens
  doi: 10.1097/00004872-199007000-00004
  contributor:
    fullname: OBrien
– volume: 8
  start-page: 1085
  year: 1990
  ident: R7-17-20110409
  publication-title: J Hypertens
  doi: 10.1097/00004872-199012000-00003
  contributor:
    fullname: Meredith
– volume: 47
  start-page: 477
  year: 1995
  ident: R9-17-20110409
  publication-title: Eur J Clin Pharmacol
  doi: 10.1007/BF00193697
  contributor:
    fullname: Detry
– volume: 12
  start-page: S67
  year: 1994
  ident: R10-17-20110409
  publication-title: J Hypertens
  doi: 10.1097/00004872-199412001-00014
  contributor:
    fullname: Waeber
– volume: 67
  start-page: 361
  year: 1990
  ident: R12-17-20110409
  publication-title: Pharmacol Toxicol
  doi: 10.1111/j.1600-0773.1990.tb00847.x
– volume: 33
  start-page: 741
  year: 1983
  ident: R6-17-20110409
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.1983.101
  contributor:
    fullname: Chrysant
– volume: 60
  start-page: 177
  year: 1988
  ident: R15-17-20110409
  publication-title: Br Heart J
  doi: 10.1136/hrt.60.3.177
  contributor:
    fullname: Evans
SSID ssj0008973
Score 1.8534048
Snippet To compare enalapril 20 mg once daily with 10 mg twice daily in terms of blood pressure reduction and patient compliance. Cross-over study of patients randomly...
OBJECTIVETo compare enalapril 20 mg once daily with 10 mg twice daily in terms of blood pressure reduction and patient compliance.DESIGNCross-over study of...
SourceID proquest
crossref
pubmed
pascalfrancis
SourceType Aggregation Database
Index Database
StartPage 1627
SubjectTerms Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Antihypertensive agents
Biological and medical sciences
Blood Pressure - drug effects
Blood Pressure Monitoring, Ambulatory
Cardiovascular system
Cross-Over Studies
Drug Administration Schedule
Enalapril - administration & dosage
Enalapril - therapeutic use
Humans
Hypertension - drug therapy
Hypertension - physiopathology
Medical sciences
Patient Compliance
Pharmacology. Drug treatments
Posture - physiology
Title A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance
URI https://www.ncbi.nlm.nih.gov/pubmed/10608477
https://search.proquest.com/docview/69370092
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELa2WwkhIcSbBQo-cIsiJbbjx3Ep21JpKQe2Um9RYnvbldrsah_qjd_O2HEeK4qAA5doNZHjaOfzZMb-Zgahj4LpObXKxoJyHTNiTSwzxmMOUkOJ1SX3TWy_i_NL-XnCJoPBXRP1t7L_qmmQga5d5uw_aLt9KAjgN-gcrqB1uP6V3seBVh5aC0YWRhSr9eImIkl0exW5NMXIFG5XwzEydpso9fLt3aK94biPYLE9y8Mz2yNPl3VnDTeuq1qT2BiKsgZeeoufX33da4h2154r3536ny7AStXN4ntb1TBtoJB86k6sfBuvwPM_DRxlE1L3VEjZ6wwa4TQGB2ff-oo-ytKeLU15XTUgfJfBcUzvtfl1LWEf7EhBHHMGQtA09Qnz4el7ZbbPv-UnF9NpPptczg7QIQELxYbocHx8Nj1rP-JS1eSE5pUDCayp93nfTHuezaNVsYFFNq-7o_w-fPFuzOwJehx0gsc1cJ6iga2eoQdfA8PiOfoxxh1-8HKOW_xgkuDbK-zwgz1McI0feGMn9_gJNxYV9vhx4z1-cIMf3OAHA35wwA_u8PMCXZxMZsdf4tCjI9aUJdtYFIIVRDGRcQOL21jGNPjcWjDFrLRUM5MlaSFcJbwyo6VRBS2VSMuSW-12SF6iYbWs7GuEqSxhpDLKmIzNiZBynnFJtTAF1RBZjFDa_L_5qi7FkvcoFF4neasTz6oQI3S0p4huIJEKnLMR-tAoJge76g7Lisoud5ucg9_uCpKN0KtaX705eQI-nXjzx7Fv0cNuHbxDw-16Z4_Qwcbs3ge8_QSZf5oG
link.rule.ids 315,782,786,27934,27935
linkProvider Ovid
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+comparison+of+enalapril+20+mg+once+daily+versus+10+mg+twice+daily+in+terms+of+blood+pressure+lowering+and+patient+compliance&rft.jtitle=Journal+of+hypertension&rft.au=Girvin%2C+B&rft.au=McDermott%2C+B+J&rft.au=Johnston%2C+G+D&rft.date=1999-11-01&rft.issn=0263-6352&rft.volume=17&rft.issue=11&rft.spage=1627&rft.epage=1631&rft_id=info:doi/10.1097%2F00004872-199917110-00017&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0263-6352&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0263-6352&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0263-6352&client=summon